With the analysis among 716 patents, we discovered top 102 key players by total patent application. FibroGen, Inc., Aerpio Therapeutics, Inc., Akebia Therapeutics, Inc. are dominant in this area. They take 35.89% of the total patent filing.
California, United States
Patent: 155
Aerpio Therapeutics, Inc.
Ohio, United States
Patent: 68
Akebia Therapeutics, Inc.
Massachusetts, United States
Patent: 34
Grifols Worldwide Operations Ltd.
DUBLIN, Ireland
Patent: 28
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 25
Roche Innovation Center Copenhagen A/S
Hovedstaden, Denmark
Patent: 19
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 13
Elara Pharmaceuticals GmbH
Baden-Württemberg, Germany
Patent: 13
undefined undefined
Patent: 12
With the analysis among 57 patents, we discovered top 5 start-ups by total patent application. NiKang Therapeutics, Inc., Shenzhen Tajirui Biomedical Co. Ltd., Oncoc4 Inc are active in this area.
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 25
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 13
undefined undefined
Patent: 12
California, United States
Patent: 6
Shenzhen Evergreen Therapeutics Co., Ltd.
Guangdong Sheng, China
Patent: 1
With the analysis among related 213 patents applied in the last 5 years. We discover 80 most active companies in this area. The fast-growing NiKang Therapeutics, Inc., Seoul University Industry Academic Cooperation Foundation, Crystal Pharmaceutical (Suzhou) Co., Ltd take 19.25% of patent filing during this period.
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 25
Seoul University Industry Academic Cooperation Foundation
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 7
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6
Grifols Worldwide Operations Ltd.
California, United States
Patent: 6
Sunshine Lake Pharma Co. Ltd.
Guangdong Sheng, China
Patent: 5
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 5
The Schepens Eye Research Institute, Inc.
Massachusetts, United States
Patent: 5
With the analysis among related 213 patents in last 5 years, we discover 62 new entrants. NiKang Therapeutics, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd, China Pharmaceutical University are the most active new entrants in this area.
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 25
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 7
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6
California, United States
Patent: 6
The Schepens Eye Research Institute, Inc.
Massachusetts, United States
Patent: 5
Illinois, United States
Patent: 4
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
Shenzhen Ruzhongbo Medical Technology Co., Ltd.
Guangdong Sheng, China
Patent: 3
With the analysis among 274 patents, we discovered top 58 universities and scientific research institutions by total patent application. The Johns Hopkins University, The Johns Hopkins University School of Medicine, The European Molecular Biology Laboratory are dominant in this area. They take 15.33% of the total patent filing.
The Johns Hopkins University
The Johns Hopkins University School of Medicine
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 11
Georgia, United States
Patent: 9
University of Mississippi
Mississippi, United States
Patent: 9
Universiti Putra Malaysia
Selangor, Malaysia
Patent: 9
Vlaams Instituut voor Biotechnologie - Flanders Institute
Gwangju Institute of Science & Technology
New York, United States
Patent: 7
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6